Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rheumatoid arthritis in older adults

K L Sewell1

  • 1Division of Aging, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. klsewell@bidmc.harvard.edu

Clinics in Geriatric Medicine
|July 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen - a proof-of-concept, randomized, double-blind, active-comparator study.

Alimentary pharmacology & therapeutics·2010
Same author

Calcitonin.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
Same author

Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1.

Clinical and experimental immunology·2005
Same author

Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease.

Alimentary pharmacology & therapeutics·2002
Same author

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Arthritis and rheumatism·1999
Same author

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene.

Arthritis and rheumatism·1997
Same journal

A Preventive Neurology Perspective on Promoting Brain Health and Preventing Cardiovascular Disease.

Clinics in geriatric medicine·2026
Same journal

Secondary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Primary Prevention in Older Adults: Putting It All Together.

Clinics in geriatric medicine·2026
Same journal

Managing Bleeding Risk in Older Adults: Antithrombotics and Anticoagulants.

Clinics in geriatric medicine·2026
Same journal

Cardiometabolic and Diabetes Management in Older Adults.

Clinics in geriatric medicine·2026
Same journal

Evaluation and Management of Hypertension in Older Adults: Current Evidence for an Age-Tailored Approach.

Clinics in geriatric medicine·2026
See all related articles

Rheumatoid arthritis in older adults presents diagnostic challenges and functional decline. Individualized, multidisciplinary care focusing on pain, depression, and tailored drug selection is crucial for managing this condition.

Area of Science:

  • Geriatric Medicine
  • Rheumatology
  • Clinical Therapeutics

Background:

  • Rheumatoid arthritis (RA) is a prevalent condition in the elderly population.
  • RA diagnosis can be complex due to diverse clinical manifestations in older adults.
  • Patients with RA face significant functional impairment and elevated risk of institutionalization.

Purpose of the Study:

  • To highlight the diagnostic challenges of rheumatoid arthritis in older adults.
  • To emphasize the importance of multidisciplinary care in managing RA-related disability.
  • To guide geriatricians in selecting appropriate therapeutic modalities for elderly RA patients.

Main Methods:

  • Review of current therapeutic options for rheumatoid arthritis in geriatric patients.
  • Discussion of factors influencing drug selection, including disease activity and toxicity risk.

Related Experiment Videos

  • Emphasis on individualized treatment strategies.

    • Main Results:

    • Rheumatoid arthritis diagnosis in older adults requires careful consideration of varied presentations.
    • Multidisciplinary care is essential to address functional decline, pain, and depression.
    • Individualized pharmacotherapy based on disease activity and patient-specific risks is recommended.

    Conclusions:

    • Effective management of rheumatoid arthritis in older adults necessitates a comprehensive, patient-centered approach.
    • Geriatricians must balance treatment efficacy with potential toxicities when selecting therapies.
    • Addressing all contributing factors to disability is key to improving outcomes for elderly RA patients.